Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quan Duzhong Capsules for Primary Osteoporosis
NCT07895082Phase 3Enrolling by invitation
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 3 trial of Eucommia ulmoides bark in primary osteoporosis, sponsored by Shanghai University of Traditional Chinese Medicine. Started Oct 2026; status: enrolling by invitation.
02
Drugs
Eucommia ulmoides bark
03
Conditions
primary osteoporosis
Beyond the preview
Go deeper on NCT07895082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895082.